83 FR 43687 - Final National Occupational Research Agenda for Traumatic Injury Prevention
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention Federal Register Volume 83, Issue 166 (August 27, 2018)
Centers for Disease Control and Prevention
Federal Register Volume 83, Issue 166 (August 27, 2018)
| Page Range | 43687-43688 | |
| FR Document | 2018-18514 |
[Federal Register Volume 83, Number 166 (Monday, August 27, 2018)] [Notices] [Pages 43687-43688] From the Federal Register Online [www.thefederalregister.org] [FR Doc No: 2018-18514] ----------------------------------------------------------------------- DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention [CDC-2017-0104; Docket Number NIOSH-304] Final National Occupational Research Agenda for Traumatic Injury Prevention AGENCY: National Institute for Occupational Safety and Health (NIOSH) of the Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS). ACTION: Notice of availability. ----------------------------------------------------------------------- SUMMARY: NIOSH announces the availability of the final National Occupational Research Agenda for Traumatic Injury Prevention. DATES: The final document was published on August 20, 2018 on the CDC website. ADDRESSES: The document may be obtained at the following link: https:// [[Page 43688]] www.cdc.gov/niosh/nora/crosssectors/ti/agenda.html. FOR FURTHER INFORMATION CONTACT: Emily Novicki, M.A., M.P.H, (NORACoordinator@cdc.gov), National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention, Mailstop E-20, 1600 Clifton Road NE, Atlanta, GA 30329, phone (404) 498-2581 (not a toll free number). SUPPLEMENTARY INFORMATION: On December 7, 2017, NIOSH published a request for public review in the Federal Register [82 FR 57758] of the draft version of the National Occupational Research Agenda for Traumatic Injury Prevention. All comments received were reviewed and addressed where appropriate. Dated: August 22, 2018. Frank J. Hearl, Chief of Staff, National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention. [FR Doc. 2018-18514 Filed 8-24-18; 8:45 am] BILLING CODE 4163-19-P
![Federal Register / Vol. 83, No. 166 / Monday, August 27, 2018 / Notices 43687
enrolled in Wave 1 (n=1,215, or 405 per the exposure and the referent group. enroll as adults; therefore, 420 parents
year), that is, will be past participants of ATSDR assumes that 5% of the people will take the child questionnaire long
the 2015–7 NH DHHS PFAS blood who volunteer will not meet eligibility form (n=140 per year), while 105
testing program. NH DHHS will assist requirements. ATSDR will screen the parents will take the short form to
ATSDR by sending out letters of 1,578 people from the NH DHHS PFAS reduce burden (n=35 per year). Parents
invitation to its former blood testing blood testing program in Wave One and children will also complete
program participants. To achieve the (n=526 per year). ATSDR will screen at assessments of the child’s attention and
desired sample size, the other 10 least 142 exposed people in Wave 2 (or behaviors. After eligibility screening,
percent of the exposure group (n=135, 47 per year), and at least 289 unexposed the annual time burden for participation
or 45 per year) will be recruited in Wave people in Wave 3 (or 96 per year). This in the study is 58 hours for adults and
2. These will be people who were will require an annual time burden of 208 hours for children and their parents.
eligible for the PFAS blood testing 124 hours for eligibility screening.
At enrollment, ATSDR will obtain ATSDR will ask for permission to
program but did not take part. The
adult consent, parental permission, and compare adults’ and children’s medical
referent group will be recruited in Wave
child assent before data collection histories with their medical records.
Three (n=275, or 92 per year), which
begins. Each child will enroll with a ATSDR will also ask for permission to
can occur concurrently with Wave 1 and
parent, who ideally will be the child’s check children’s school records to
Wave 2. Wave 2 and Wave 3 recruits
birth mother, as ATSDR will ask details compare their behavioral assessment
will call to volunteer after ATSDR opens
those waves to enrollment. about the child’s exposure, pregnancy, results. The annual time burden for
To restrict this study to drinking and breastfeeding history. medical and educational record
water exposures, any adult For each participant, ATSDR will take abstraction is estimated to be 125 hours
occupationally exposed to PFAS will body measures, collect blood and urine for adult records and 118 hours for
not be eligible for the study (i.e. ever samples for chemical and biomarker children’s records.
firefighters or in chemical manufacture). analysis, and administer a questionnaire The total annualized time burden
Likewise, children whose birth mothers on exposures and medical history. For requested is 1,189 hours. There is no
were occupationally exposed will not be purposes of burden estimation, ATSDR cost to the respondents other than their
eligible. This restriction applies to both assumes that 20% of parents will also time.
ESTIMATED ANNUALIZED BURDEN HOURS
Average
Number of
Number of burden per Total burden
Type of respondents Form name responses per
respondents response (in hours)
respondent (in hours)
Pease Study Participants Wave One Eligibility Screening Script ................. 526 1 10/60 88
Wave Two Eligibility Screening Script ................. 47 1 15/60 12
Wave Three Eligibility Screening Script .............. 96 1 15/60 24
Appointment Reminder Telephone Script ........... 542 1 5/60 45
Update Contact Information Hardcopy Form ...... 542 1 5/60 45
Medication List ..................................................... 542 1 3/60 27
Body and Blood Pressure Measures Form ......... 542 1 5/60 45
Blood Draw and Urine Collection Form .............. 542 1 10/60 90
Adult Questionnaire ............................................. 367 1 30/60 184
Child Questionnaire—Long Form ........................ 140 1 30/60 70
Child Questionnaire—Short Form ....................... 35 1 15/60 9
Parent Neurobehavioral Test Battery .................. 175 1 15/60 44
Child Neurobehavioral Test Battery .................... 175 1 90/60 263
Education Specialists .... Child School Record Abstraction Form ............... 15 12 20/60 60
Medical Record Special- Medical Record Abstraction Form—Adult ........... 25 15 20/60 125
ists.
Medical Record Abstraction Form—Child ........... 25 7 20/60 58
Total ........................ .............................................................................. ........................ ........................ ........................ 1,189
Jeffrey M. Zirger, DEPARTMENT OF HEALTH AND Control and Prevention (CDC),
Acting Chief, Information Collection Review HUMAN SERVICES Department of Health and Human
Office, Office of Scientific Integrity, Office Services (HHS).
of the Associate Director for Science, Office Centers for Disease Control and
ACTION: Notice of availability.
of the Director, Centers for Disease Control Prevention
and Prevention.
SUMMARY: NIOSH announces the
[FR Doc. 2018–18446 Filed 8–24–18; 8:45 am] [CDC–2017–0104; Docket Number NIOSH–
availability of the final National
BILLING CODE 4163–18–P 304]
Occupational Research Agenda for
amozie on DSK3GDR082PROD with NOTICES1
Final National Occupational Research Traumatic Injury Prevention.
Agenda for Traumatic Injury DATES: The final document was
Prevention published on August 20, 2018 on the
AGENCY: National Institute for CDC website.
Occupational Safety and Health ADDRESSES: The document may be
(NIOSH) of the Centers for Disease obtained at the following link: https://
VerDate Sep<11>2014 17:51 Aug 24, 2018 Jkt 244001 PO 00000 Frm 00054 Fmt 4703 Sfmt 4703 E:\FR\FM\27AUN1.SGM 27AUN1](https://thefederalregister.org/doc/83_FR_43853/page/1.svg)
![43688 Federal Register / Vol. 83, No. 166 / Monday, August 27, 2018 / Notices
www.cdc.gov/niosh/nora/crosssectors/ (b) Evaluate the accuracy of the management strategies to reduce HIV-
ti/agenda.html. agencies estimate of the burden of the related morbidity and mortality (e.g.,
FOR FURTHER INFORMATION CONTACT: proposed collection of information, effectiveness of antiretroviral therapies
Emily Novicki, M.A., M.P.H, including the validity of the and other clinical interventions (iii)
(NORACoordinator@cdc.gov), National methodology and assumptions used; monitoring of sexual and drug use
Institute for Occupational Safety and (c) Enhance the quality, utility, and behaviors to inform Prevention with
Health, Centers for Disease Control and clarity of the information to be Positives, and (iv) investigating
Prevention, Mailstop E–20, 1600 Clifton collected; disparities in the HIV care continuum
Road NE, Atlanta, GA 30329, phone (d) Minimize the burden of the by various demographic factors. In
(404) 498–2581 (not a toll free number). collection of information on those who recent years, the HOPS has been
are to respond, including, through the instrumental in bringing attention to
SUPPLEMENTARY INFORMATION: On
use of appropriate automated, emerging issues in chronic HIV
December 7, 2017, NIOSH published a electronic, mechanical, or other
request for public review in the Federal infection with actionable opportunities
technological collection techniques or for prevention, including:
Register [82 FR 57758] of the draft other forms of information technology,
version of the National Occupational Cardiovascular disease, fragility
e.g., permitting electronic submission of fractures, renal and hepatic disease, and
Research Agenda for Traumatic Injury responses; and
Prevention. All comments received were cancers. The HOPS remains an
(e) Assess information collection important source for multi-year trend
reviewed and addressed where costs.
appropriate. data concerning conditions and
To request additional information on behaviors for which data are not readily
Dated: August 22, 2018. the proposed project or to obtain a copy available elsewhere, including: Rates of
Frank J. Hearl, of the information collection plan and opportunistic illnesses, rates of
Chief of Staff, National Institute for instruments, call (404) 639–7570 or comorbid conditions (e.g., hypertension,
Occupational Safety and Health, Centers for send an email to omb@cdc.gov. Direct obesity, diabetes) and antiretroviral drug
Disease Control and Prevention. written comments and/or suggestions resistance.
[FR Doc. 2018–18514 Filed 8–24–18; 8:45 am] regarding the items contained in this Data will be collected through
BILLING CODE 4163–19–P notice to the Attention: CDC Desk medical record abstraction by trained
Officer, Office of Management and abstractors and by telephone or internet-
Budget, 725 17th Street, NW, based, computer-assisted interviews at
DEPARTMENT OF HEALTH AND Washington, DC 20503 or by fax to (202) eight funded study sites in six U.S.
HUMAN SERVICES 395–5806. Provide written comments cities. Collection of data abstracted from
within 30 days of notice publication. patient medical records provides data in
Centers for Disease Control and
Proposed Project five general categories: Demographics
Prevention
HIV Outpatient Study (HOPS) (OMB and risk behaviors for HIV infection;
Control Number 0920–1080, Expiration symptoms; diagnosed conditions
[30Day–18–1080] (definitive and presumptive);
Date 08/31/2018)—REVISION—National
Center for HIV/AIDS, Viral Hepatitis, medications prescribed (including dose,
Agency Forms Undergoing Paperwork
STD, and TB Prevention (NCHHSTP), duration, and reasons for stopping); all
Reduction Act Review
Centers for Disease Control and laboratory values, including CD4+ T-
In accordance with the Paperwork Prevention (CDC). lymphocyte (CD4+) cell counts, plasma
Reduction Act of 1995, the Centers for HIV–RNA determinations, and
Disease Control and Prevention (CDC) Background and Brief Description genotype, phenotype, and trophile
has submitted the information The Centers for Disease Control and results. Data on visit frequency, AIDS,
collection request titled [HIV Outpatient Prevention requests a three year and death are acquired from the clinic
Study (HOPS)] to the Office of approval for the HIV Outpatient Study chart.
Management and Budget (OMB) for data collection activity. The HIV Data collected using a brief Telephone
review and approval. CDC previously Outpatient Study (HOPS) is a Audio-Computer Assisted Self-
published a ‘‘Proposed Data Collection prospective longitudinal cohort of HIV- Interview (T–ACASI) survey or an
Submitted for Public Comment and infected outpatients at eight well- identical web-based Audio-Computer
Recommendations’’ notice on established private HIV care practices Assisted Self-Interview (ACASI)
[September 26, 2017] to obtain and university-based U.S. clinics. include: age, sex at birth, use of alcohol
comments from the public and affected Clinical data are abstracted on ongoing and drugs, cigarette smoking, adherence
agencies. CDC received [2] comments basis from the medical records of adult to antiretroviral medications, types of
related to the previous notice. This HIV-infected HOPS study participants, sexual intercourse, condom use, and
notice serves to allow an additional 30 who also complete an optional seven disclosure of HIV status to partners.
days for public and affected agency minute telephone/web-based behavioral We estimate consenting 450 new
comments. assessment as part of their annual clinic participants per year across all HOPS
CDC will accept all comments for this visit. Before enrolling in this study, all study sites (50 participants at each of
proposed information collection project. potential study participants will the eight sites). The consent process
The Office of Management and Budget undergo an informed consent process takes approximately 15 minutes to
is particularly interested in comments (including signing of a written informed complete. Medical record abstractions
amozie on DSK3GDR082PROD with NOTICES1
that: consent) which is estimated to take 15 will be completed on all eligible
(a) Evaluate whether the proposed minutes. participants. All eligible participants
collection of information is necessary The core areas of HOPS research will be offered the opportunity to
for the proper performance of the extending through the present HIV participate in an optional short survey
functions of the agency, including treatment era include (i) monitoring that will take approximately seven
whether the information will have death rates and causes of death (ii) minutes. Participation of respondents is
practical utility; characterizing the optimal patient voluntary. There is no cost to the
VerDate Sep<11>2014 17:51 Aug 24, 2018 Jkt 244001 PO 00000 Frm 00055 Fmt 4703 Sfmt 4703 E:\FR\FM\27AUN1.SGM 27AUN1](https://thefederalregister.org/doc/83_FR_43853/page/2.svg)
Document Created: 2018-08-25 01:49:39
Document Modified: 2018-08-25 01:49:39
| Category | Regulatory Information | |
| Collection | Federal Register | |
| sudoc Class | AE 2.7: GS 4.107: AE 2.106: | |
| Publisher | Office of the Federal Register, National Archives and Records Administration | |
| Section | Notices | |
| Action | Notice of availability. | |
| Dates | The final document was published on August 20, 2018 on the CDC website. | |
| Contact | Emily Novicki, M.A., M.P.H, ([email protected]), National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention, Mailstop E-20, 1600 Clifton Road NE, Atlanta, GA 30329, phone (404) 498-2581 (not a toll free number). | |
| FR Citation | 83 FR 43687 |
2024 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR